2023 Webinar: Terlipressin in AKI-HRS
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered

This will be a single lecture reviewing the differential diagnosis of AKI, including a focus on AKI-HRS, and then review management strategies.  There will be focus on terlipressin given its the publication of the recent NA RCT and its FDA approval, including indications, contraindications, and potential side effects (including the important pulmonary side effects).

Presenters: Pratima Sharma, University of Michigan
Moderator: Florence Wong, University of Toronto


This webinar was originally presented on July 20, 2023.
Powered By